The JADPRO Podcast

Seeing an increase in interventional radiology (IR) referrals and patient wait times, in 2019, an advanced practitioner mobile IR team was started to perform paracentesis and thoracentesis at a major cancer center. Hear from Caitlin Treacy, MS, AGACNP, of Memorial Sloan Kettering Cancer Center, on this advanced practitioner–led team, including hiring, training, and outcomes. This poster received the Outstanding Poster Award at JADPRO Live 2021.

Related Content:
(JL910) Implementation and Impact of an Advanced Practice Provider-Led Bedside Procedural Team at a Major Cancer Institution

The ninth annual JADPRO Live conference wrapped up in October, and Wendy Vogel, MSN, FNP, AOCNP®, Executive Director of APSHO, and Annie Yueh, Editor of JADPRO, take a look back at their favorite moments, interesting statistics, and attendee feedback. 

Related Content:

Episode 46: Your True Self: A New Take on How to Combat Burnout

The Mary Pazdur Award for Excellence in Advanced Practice in Oncology

On this episode of “MPN Expertise for APPs by APPs,” Heather Bowers, ACNP, and Sara Tinsley, PhD, APRN, share their thoughts on the critical role advanced practice providers play in helping to provide education and optimize care for patients with polycythemia vera (PV).

Cancer-related fatigue (CRF) is one of the most prevalent, debilitating symptoms for patients with cancer. It is also a multifactorial problem for which there is no one solution. Emily A. Lemke, DNP, AGPCNP-BC, AOCNP, of the Medical College of Wisconsin, summarizes data on one potential option: 2,000 mg of American ginseng daily. She reviews the safety and efficacy, where to source it, and tools to measure fatigue in patients.

Related Content:

Ginseng for the Management of Cancer-Related Fatigue: An Integrative Review. J Adv Pract Oncol 2021;12(4):406–414
Ginseng (American) in About Herbs
Ginseng Board of Wisconsin
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016 Feb;81:9-13
MFSI (Multidimensional Fatigue Symptoms Inventory)
ESAS (Edmonton Symptom Assessment System)

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC). While most cancer programs in the United States report that they employ advanced practitioners (APs), they are often not utilized to the full scope of their abilities in clinical research.

In this episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, shares the evolution of the advanced practitioner role at her institution, where APs have a larger voice in the research process and clinical trial protocols, serve as champions to advocate for patients and research staff, and collaborate with their team to promote best practices in clinical trial delivery.

On this episode of “MPN Expertise for APPs by APPs,” Heather Bowers, ACNP, and Kristi Wiggins, MSN, ANP-BC, share their strategies for assessing spleen size in myelofibrosis (MF), as well as the presence and severity of MF-related symptoms.

NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Myeloproliferative Neoplasms V.1.2021. © National Comprehensive Cancer Network, Inc. 2021. All rights reserved. Accessed May 11, 2021. To view the most recent and complete version of the guideline, go online to NCCN.org

Related Content:

The Way of Integrity by Martha Beck
Brené Brown's List of Values

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, of Atrium Health, Levine Cancer Institute, in Concord, North Carolina, talks with host Wendy Vogel, MSN, FNP, AOCNP®, on recent data and strategies for managing adverse events of ibrutinib, acalabrutinib, and zanubrutinib in the treatment of B-cell malignancies.

Related Content:

A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies. J Adv Pract Oncol 2021;12(4):439–447. https://doi.org/10.6004/jadpro.2021.12.4.8

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC). Listen about how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversity in clinical trials by bringing their experience to trial design and the accrual process.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused on one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.

Related Content:

Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study. J Adv Pract Oncol 2021;12(5):465–476.

This week, we're sharing an episode from Cancer Buzz, the podcast of the Association of Community Cancer Centers (ACCC).

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused on one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.